PAGLIACCI, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 206
EU - Europa 120
AS - Asia 54
AF - Africa 13
SA - Sud America 3
Totale 396
Nazione #
US - Stati Uniti d'America 206
IT - Italia 34
UA - Ucraina 20
CN - Cina 18
RU - Federazione Russa 14
SE - Svezia 14
TR - Turchia 14
IE - Irlanda 13
DE - Germania 12
SG - Singapore 11
CI - Costa d'Avorio 10
DK - Danimarca 7
HK - Hong Kong 6
FI - Finlandia 4
KR - Corea 4
BR - Brasile 3
MA - Marocco 3
CZ - Repubblica Ceca 1
GB - Regno Unito 1
IN - India 1
Totale 396
Città #
Chandler 29
Fairfield 20
Jacksonville 20
Ashburn 13
Dublin 13
Boardman 12
New York 12
Abidjan 10
Houston 10
Seattle 10
Centro 9
Wilmington 9
Porto 8
Singapore 7
Cambridge 6
Hong Kong 6
Chiaravalle 5
Woodbridge 5
Ancona 4
Dallas 4
Guangzhou 4
Lawrence 4
Princeton 4
San Mateo 4
Beijing 3
Ann Arbor 2
Moscow 2
Rome 2
San Diego 2
San Francisco 2
The Dalles 2
Arqua Petrarca 1
Ascoli Piceno 1
Baoding 1
Birmingham 1
Bursa 1
Cerquilho 1
Dalian 1
Jequié 1
Kilburn 1
Nanning 1
Olomouc 1
Petrolina 1
Phoenix 1
Pune 1
Suzhou 1
Turin 1
Washington 1
Xi'an 1
Totale 261
Nome #
Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients 113
Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations. 96
Paclitaxel and Bevacizumab in First Line-Treatment Patients with HER-2 Negative Advanced Breast Cancer: Who could Benefit? 82
Everolimus and exemestane in long survival hormone receptor positive male breast cancer: case report 79
Primum non Nocere: How to ensure continuity of care and prevent cancer patients from being overlooked during the COVID- 19 pandemic 40
Totale 410
Categoria #
all - tutte 2.082
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.082


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 0 0 0 0 1 6
2020/202178 5 7 9 0 9 5 6 5 6 16 9 1
2021/202233 5 7 0 0 0 3 1 2 2 5 2 6
2022/202371 5 12 4 6 7 10 0 0 20 2 3 2
2023/202456 10 3 1 7 5 18 3 4 0 0 0 5
2024/202584 21 12 2 3 6 3 2 2 17 4 12 0
Totale 410